Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: A study of occupationally exposed men

American Journal of Industrial Medicine

Volumn 29, Issue 5, 1996, Pages 560-568

  Gilliland, Frank D ^a,b,c   Mandel, Jack S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b REGIONS HOSPITAL   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

cholesterol; HDL; hepatic enzymes; human; perfluorooctanoic acid

Indexed keywords

CHOLESTEROL; LIPOPROTEIN; LIVER ENZYME; PERFLUOROOCTANOIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; ENZYME ANALYSIS; HEPATOMEGALY; HUMAN; HYPOLIPEMIA; LIPOPROTEIN BLOOD LEVEL; LIVER NECROSIS; OCCUPATIONAL EXPOSURE; SMOKING;

ADULT; ALANINE TRANSAMINASE; ALCOHOL DRINKING; ASPARTATE AMINOTRANSFERASES; BODY MASS INDEX; CHEMICAL INDUSTRY; CHOLESTEROL; FLUORINE; FLUOROCARBONS; HUMANS; LIPOPROTEINS; LIVER; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; OCTANOIC ACIDS; SMOKING;

EID: 0029939198     PISSN: 02713586     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0274(199605)29:5<560::AID-AJIM17>3.0.CO;2-Z     Document Type: Article

References (29)

1. Abdellatif A, Preat V, Vamecq J, Nilsson R, Roberfroid M (1990): Peroxysome proliferation and modulation of rat liver carcinogenesis by 2,3-dichlorophenoxyacetic acid, 2,4,5 trichlororphenoxyacetic acid, perfluorooctanoic acid and nafenopin. Carcinogenesis 11:1899-1902.
2. Bates H (1981): GGTP and alcoholism: A sober look. Lab Management 19:1-3.
3. Belisle J (1981) Organic fluoride in human serum: Natural versus industrial sources. Science 212:1509-1510.
4. Gilliland F, Mandel J (1993): Mortality among employees in a PFOA production plant. J Occup Med. 35:950-954.
5. Griffith F, Long J (1980): Animal toxicity studies with ammonium perfluorooctanoate. Am Ind Hyg Assoc 41:576-583.
6. Guy W (1979): Ionic and organic fluorine in blood. In Johansen E, Taves D, Olsen T (eds): Continuing Evaluation of the Use of Fluoride. Boulder, CO: Westview Press.
7. Haughom B, Spydevold O. (1992): The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid. Biochim Biophys Acta 1128:65-72.
8. Hodgson M, Van Theil D, Lauschus K, Karpf M (1989): Liver injury tests in harzardous waste workers: The role of obesity. J Occup Med 31:238-242.
9. Just W, Gorgas K, Hartl F, Heinemann P, Salazar M, Schimassek H (1989): Biochemical effects and zonal heterogeneity of peroxisome proliferation induced by perfluorocarboxylic acids in rat liver. Hepatology 9:570-581.
10. Keller B, Marsman D, Popp J, Thurman R (1992): Several nongenotoxic carcinogens uncouple mitochondrial oxidative phosphorylation. Biochim Biophys Acta 1102:237-244.
11. Kennedy G (1985): Dermal toxicity of ammonium perfluorooctanoate. Toxicol Appl Pharmacol 81:348-355.
12. Kennedy G, Hall G, Brittelli J Chen H (1986): Inhalation toxicity of ammonium perfluoroctanoate Food Chem Toxic 24:1325-1329.
13. Ludwig J, Viggiano T, McGill D, Ott B (1980): Nonalcoholic steatohepatitis. Mayo Clin Proc 55:434-438.
14. Nilsson R, Beije B, Preat V, Erixon K, Ramel C (1991): On the mechanism of the hepatocarcinogenicity of peroxisome proliferators. Chem Biol Interact 78:235-50.
15. Orrego H, Blake J, Israel Y (1985): Relationship between gamma glutamyl transpeptidase and mean urinary alcohol levels in alcoholics while drinking and in withdrawal. Alcohol Clin Exp Res 9:10-13.
16. Pastoor T, Lee K, Perri M, Gillies P (1987): Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation. Exp Mol Pathol 47:98-109.
17. Perkins R (1992): Investigation of ammonium perfluorooctanate effect on hormone levels and peroxysome proliferation in the rat. Toxicologist 12:38.
18. Permadi H, Lundgren B, Andersson K, DePierre, J. (1992): Effects of perfluoro fatty acids on xenobiotic-metabolizing enzymes, enzymes which detoxify reactive forms of oxygen and lipid peroxidation in mouse liver. Biochem Pharmacol 44:1183-1191.
19. Reddy J, Azarnoff D, Hignite C (1980): Hypolipidemic hepatic peroxisome proliferators form a novel class of chenical carcinogens. Nature 283:397-398.
20. Schuckit M, Griffiths J (1982): Gamma glutamyltransferase values in non-alcoholic drinking men. Am J Psychiatry 139:227-228
21. Schuckit M, Irwin M (1988): Diagnosis of alcoholism. Med Clin North Am 72:1133-1153.
22. Sohlenius K, Andersson K, DePierre J (1992): The effects, of perfluorooctanoic acid on hepatic peroxisome proliferation and related parameters show no sex-related differences in mice. Biochem Toxicol. 285:779-783.
23. Statistical Analysis System (1992). "SAS User's Guide, Version 6." Cary, NC: SAS Institute, Inc.
24. Takagi A, Sai K, Umemura T, Hasegawa R Kurokawa Y (1991): Short-term exposure to the peroxisome proliferators, perfluoooctanoic acid and perfluorodecanoic acid, causes significant increases of 8-hydroxydeoxyguanosine in liver DNA of rats. Cancer Lett 57:55-60.
25. Taves D (1971): Comparison of "organic"fluoride in human and nonhuinan serums. J Dent Res 50:783.
26. Taves D, Guy W, Brey W (1976): Organic fluorocarbons in human plasma: Prevalence and characterization. In Filler R (ed): "Biochemistry Involving Carbon-Fluorine Bonds" Washington DC: American Chemical Society, pp 117-134.
27. Ubel F, Sorenson S, Roach D (1980): Health status of plant workers exposed to fluorochemicals: A preliminary report Am Ind Hyg Assoc 41:584-589.
28. Van Rafelghem M, Mattie D, Bruner R, Andersen M (1987): Patholgoical and hepatic ultrastructural effects of a single dose of perfluoro-n-decanoic acid in the rat, hamster, mouse and guinea pig. Fundam Appl Toxicol 9:522-540
29. Venkateswarlu P (1982): Sodium biphenyl method for determination of covalently bound fluorine in organic compounds and biological materials. Anal Chem 54:1132-1137.